
AstraZeneca Invests $2.5 Billion to Establish Global Strategic R&D Center, Support Biotech Agreements, and Boost ...
On March 21, 2025, AstraZeneca announced that it plans to invest $2.5 billion in Beijing over the next five years to establish a new global strategic R&D center. The investment also aims to support major research and manufacturing agreements to further …